Incretin-based agents in type 2 diabetic patients at cardiovascular risk: compare the effect of GLP-1 agonists and DPP-4 inhibitors on cardiovascular and pancreatic outcomes - Zhang, Z; Chen, X; Lu, P (Cardiovasc Diabetol, 2017)
et al.